Manufacturing roundup: AstraZeneca and Samsung ink $350M deal; Michigan CDMO completes expansion
Samsung’s biotech arm and AstraZeneca are looking to work together on a contract manufacturing agreement.
According to a report from Korea …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
